BeOne Medicines Ltd. Insider Trading Activity
Every SEC Form 4 insider transaction reported for BeOne Medicines Ltd. (ONC), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are ONC insiders buying or selling?
BeOne Medicines Ltd. insiders reported 3 open-market buys ($877.9M) and 289 sells ($6.4B) across 292 Form 4 filings — a net selling position of $5.5B.
Source: SEC EDGAR Form 4
Key Statistics (as of Aug 27, 2026)
Insider sentiment
Net sellingNet insider flow of $5.5B in net selling.
Recent ONC insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Xiaobin Wu | President and COO | Sale | 280 | $380.00 | $106.4K |
| Aug 14, 2026 | Chan Henry Lee | SVP, General Counsel | Sale | 2.7K | $360.00 | $959.8K |
| Aug 12, 2026 | John Oyler | Chief Executive Officer | Sale | 240.8K | $359.12 | $86.5M |
| Aug 5, 2026 | Aaron Rosenberg | Chief Financial Officer | Sale | 1.2K | $312.71 | $361.8K |
| Aug 3, 2026 | Chan Henry Lee | SVP, General Counsel | Sale | 1.0K | $323.69 | $337.9K |
| Jul 24, 2026 | Chan Henry Lee | SVP, General Counsel | Sale | 1.7K | $325.00 | $542.4K |
| Jul 17, 2026 | John Oyler | Chief Executive Officer | Sale | 64.6K | $312.00 | $20.2M |
| Jul 17, 2026 | John Oyler | Chief Executive Officer | Sale | 283.2K | $315.56 | $89.4M |
| Jul 15, 2026 | John Oyler | Chief Executive Officer | Sale | 145.9K | $305.95 | $44.6M |
| Jul 15, 2026 | John Oyler | Chief Executive Officer | Sale | 60.2K | $303.18 | $18.3M |
| Jun 25, 2026 | Xiaobin Wu | President and COO | Sale | 1.3K | $276.26 | $356.9K |
| Jun 25, 2026 | John Oyler | Chief Executive Officer | Sale | 3.4K | $273.78 | $933.6K |
| Jun 25, 2026 | Lai Wang | President, Global Head of R&D | Sale | 1.1K | $276.74 | $295.6K |
| Jun 18, 2026 | Xiaobin Wu | President and COO | Sale | 1.4K | $266.76 | $362.0K |
| Jun 18, 2026 | John Oyler | Chief Executive Officer | Sale | 3.7K | $265.55 | $980.7K |
| Jun 18, 2026 | Chan Henry Lee | SVP, General Counsel | Sale | 590 | $265.98 | $156.9K |
| Jun 18, 2026 | Lai Wang | President, Global Head of R&D | Sale | 1.2K | $265.39 | $310.2K |
| Jun 15, 2026 | Titus B. Ball | Principal Accounting Officer | Sale | 169 | $257.20 | $43.5K |
| Jun 15, 2026 | Lai Wang | President, Global Head of R&D | Sale | 756 | $261.00 | $197.3K |
| Jun 15, 2026 | Aaron Rosenberg | Chief Financial Officer | Sale | 631 | $257.74 | $162.6K |
| Jun 15, 2026 | Xiaobin Wu | President and COO | Sale | 626 | $261.20 | $163.5K |
| Jun 15, 2026 | Chan Henry Lee | SVP, General Counsel | Sale | 428 | $257.64 | $110.3K |
| Jun 15, 2026 | John Oyler | Chief Executive Officer | Sale | 1.9K | $257.24 | $501.4K |
| Jun 10, 2026 | Titus B. Ball | Principal Accounting Officer | Sale | 136 | $271.33 | $36.9K |
| Jun 10, 2026 | Chan Henry Lee | SVP, General Counsel | Sale | 871 | $270.42 | $235.5K |
Showing the 25 most recent of 292 Form 4 filings for BeOne Medicines Ltd..
Most active ONC insiders
- John Oyler58 filings
- Jane Huang43 filings
- Xiaobin Wu40 filings
- Xiaodong Wang38 filings
- Chan Henry Lee25 filings
Ask anything about ONC insider activity
Use Trabud's AI agent to query BeOne Medicines Ltd.'s Form 4 history in plain English — "Show me ONC CEO purchases this year" or compare it against any other ticker.
Open the AI agentONC insider trading FAQ
Are BeOne Medicines Ltd. insiders buying or selling?
Across 292 SEC Form 4 filings, BeOne Medicines Ltd. (ONC) insiders reported 3 open-market purchases totaling $877.9M and 289 sales totaling $6.4B. That is a net selling position of $5.5B.
How many insiders trade ONC stock?
21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for BeOne Medicines Ltd.. The most recent filing was accepted on Aug 27, 2026.
Where does Trabud get ONC insider trading data?
All ONC insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.